#USA #Sacramento #Menopause #KilgourMD #Dr. James Kilgour

KilgourMD's Groundbreaking Clinical Trial Results

In a landmark announcement, KilgourMD, a pioneering brand founded by dermatologist Dr. James Kilgour, has unveiled impressive results from a Phase II clinical trial focusing on a hair loss system tailored for menopausal women. Conducted over four months, the trial tested the effectiveness of KilgourMD’s Prevention and Treatment Serums among a significant yet often overlooked demographic—43 women suffering from androgenetic alopecia due to menopause.

The Study: Methodology and Outcomes

Unlike previous studies in the field, this trial had stringent eligibility criteria requiring participants to have clinical levels of hair loss. This approach ensured that the results truly reflected the therapeutic impact of the products rather than subjective consumer reports. The trial's outcomes were evaluated through objective measures conducted by dermatologists. By the end of the study:

• - 53% of participants achieved a minimum half-grade improvement on the modified Female Ludwig scale, which dermatologists recognize as a significant visual change.
• - An impressive 26% of the women in the trial noted a complete one-grade improvement within the mere span of four months. For context, these results rival or even surpass the outcomes typically seen with more conventional pharmaceutical treatments, such as minoxidil and finasteride, which usually take six to twelve months to show similar benefits.

Moreover, the participants experienced an average improvement of 11.1% in their Ludwig score, highlighting the system's efficacy in promoting hair regrowth quickly.

Significance of Results

In addition to hair regrowth, the trial also produced remarkable findings regarding hair shedding. By the four-month mark, standardized assessments had reported a staggering 60% reduction in hair shedding. Early indicators of success were observed as soon as day 45, when over 95% of participants displayed a decrease in shedding, a promising sign for those facing the emotional and psychological toll of hair loss.

Improvements were verified not just through clinical evaluations but also through consumer-reported outcomes. More than 80% of women claimed noticeable enhancements in hair density, health, and overall appearance by trial's conclusion.

A Focus on Menopausal Women

Dr. Kilgour highlighted the urgency of this research, noting that menopausal women have been excluded from many traditional hair loss studies despite facing some of the most challenging forms of thinning hair. The clinical results validate the effectiveness of KilgourMD's hair loss solutions while underscoring the necessity for targeted research in this demographic.

This trial marks a significant advancement in hair loss treatment options, demonstrating that effective improvement can occur in months rather than years. The comprehensive findings will soon undergo peer review, with expectations for publication within the year.

About KilgourMD

Founded by Dr. James Kilgour, KilgourMD is at the forefront of a scalp health revolution. The brand originated from Dr. Kilgour’s personal experiences observing his mother’s struggle with menopausal hair loss. He realized that even with medical assistance, many lack effective treatments free from adverse side effects. KilgourMD utilizes cutting-edge formulations designed for multiple hair types and focuses on sustainable scalp health through consistent care, aiming for fuller and stronger hair for everyone.

As they progress towards setting new benchmarks for hair loss treatments, KilgourMD emphasizes the importance of taking a research-backed and empathetic approach to scalp health.